Outlook Therapeutics, Inc.
OTLKCIK 0001649989 · Every Form 4 filed by insiders at this issuer.
Filings
14
Latest Mar 29, 2024
Unique insiders
13
Showing
14 of 14
Page 1
Top insiders
Most active reporters at Outlook Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Evanson Jeff | Officer | 2 |
| Haddadin Yezan Munther | Director | 2 |
| Auffarth Gerd | Director | 1 |
| GMS Ventures & Investments | Director10% Owner | 1 |
| Gangolli Julian S | Director | 1 |
| HILZINGER KURT J | Director | 1 |
| Haller Julia A | Director | 1 |
| Huang Andong | Director | 1 |
| KENYON LAWRENCE A | OfficerDirector | 1 |
| Sukhtian Faisal Ghiath | Director | 1 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 29, 2024 | Haddadin Yezan Munther Director | P | 1,881.71 | $11.82 | $22,242 | |
| Mar 22, 2024 | TRENARY C RUSSELL III CEO AND PRESIDENT · Director | Holdings only | — | — | — | |
| Mar 22, 2024 | KENYON LAWRENCE A CHIEF FINANCIAL OFFICER · Director | Holdings only | — | — | — | |
| Mar 22, 2024 | Evanson Jeff CHIEF COMMERCIAL OFFICER | Holdings only | — | — | — | |
| Mar 20, 2024 | Sukhtian Ghiath M. Director · 10% Owner | A | 2,305,714 | — | — | |
| Mar 11, 2024 | Evanson Jeff CHIEF COMMERCIAL OFFICER | P | 62,484 | $0.42 | $26,243 | |
| Mar 8, 2024 | THURMAN RANDY H Director | Holdings only | — | — | — | |
| Mar 8, 2024 | HILZINGER KURT J Director | Holdings only | — | — | — | |
| Mar 8, 2024 | Sukhtian Faisal Ghiath Director | Holdings only | — | — | — | |
| Mar 8, 2024 | Haddadin Yezan Munther Director | Holdings only | — | — | — | |
| Mar 8, 2024 | Gangolli Julian S Director | Holdings only | — | — | — | |
| Mar 8, 2024 | Auffarth Gerd Director | Holdings only | — | — | — | |
| Mar 8, 2024 | Huang Andong Director | Holdings only | — | — | — | |
| Mar 8, 2024 | Haller Julia A Director | Holdings only | — | — | — |
Showing 1–14 of 14
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.